Innova Self Expanding Stent System
BOSTON SCIENTIFIC CORPORATION · Decision date Aug 6, 2026
What did the FDA decide?
FDA records P140028/S087 as a supplement to PMA P140028, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 6, 2026.
FDA approval order statement
approval for adding an additional stent passivator to the line
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 6, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P140028/S087
- Regulatory pathway
- PMA supplement
- Applicant
- BOSTON SCIENTIFIC CORPORATION
- Product code
- NIP
- Decision code
- OK30
- Decision date
- Aug 6, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: STENT, SUPERFICIAL FEMORAL ARTERY.
- Applicant
- Boston Scientific Corporation
- Product code
- NIP
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P140028/S083 · Related supplement
lnnova Vascular Self Expanding Stent
P140028/S084 · Related supplement
Innova Vascular Self-Expanding Stent System
P140028/S085 · Related supplement
Innova Vascular Self-Expanding Stent System
P140028/S087 received
Application receipt date recorded by FDA.
P140028/S087 · FDA decision
30-Day Notice
P140028/S088 · Related supplement
Innova Vascular Self-Expanding Stent with Delivery System
Timeline entries are records held by MedtechLedger for P140028. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P140028
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
lnnova Vascular Self Expanding StentP140028/S083 | BOSTON SCIENTIFIC CORPORATION | PMA supplement | Aug 8, 2025 | FDA |
Innova Vascular Self-Expanding Stent SystemP140028/S084 | BOSTON SCIENTIFIC CORPORATION | PMA supplement | Oct 24, 2025 | FDA |
Innova Vascular Self-Expanding Stent SystemP140028/S085 | BOSTON SCIENTIFIC CORPORATION | PMA supplement | May 6, 2026 | FDA |
| BOSTON SCIENTIFIC CORPORATION | PMA supplement | Aug 21, 2026 | FDA |
Explore the linked device profile
Other records with product code NIP
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Supera Peripheral Stent SystemP120020/S037 | Abbott Vascular (Idef Technologies Inc) | PMA supplement | Nov 6, 2026 | FDA |
| Medtronic Vascular, Inc. | PMA supplement | Nov 5, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
| Cordis US Corporation | PMA supplement | Oct 15, 2026 | FDA | |
| Biotronik AG | PMA supplement | Sep 11, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Boston Scientific Corporation
- Headquarters
- Not reported
- Brand website
- bostonscientific.com
- FDA applicant address
- One Scimed Pl., Maple Grove, MN, 55311
Sources and methodology
- Original FDA record: P140028/S087
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




